Neuronetics, Inc. Common Stock STIM
Key Stats
- Today's Range
- $1.21 – $1.56
- 50-Day Range
- $1.11 – $2.48
- 52-Week Range
- $0.80 – $4.85
- Volume
- 3.48 million shs
- Average Volume
- 2.69 million shs
- Market Cap
- $107.17 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 6.28
- Price / Sales
- —
Short Interest
- Short Interest
- 0.01%
- Days to Cover
- 1.00
About Neuronetics, Inc. Common Stock
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.